1. Introduction {#sec1}
===============

Cellulitis is a bacterial infection of the skin involving the dermis and subcutaneous fat. In Australia, cellulitis accounts for over 250,000 hospital bed days, or 10.5% of potentially preventable hospitalizations \[[@bib1]\].While most episodes of cellulitis can be managed as an outpatient, a significant proportion, particularly older people, require hospitalization. Over a 12-month period from 2014 to 2015, the cellulitis hospitalization rate was 1100 per 100,000 in the 80 plus age group as opposed to 237 episodes per 100,000 in the general population \[[@bib1]\].

Cellulitis typically presents with pain, erythema, warmth and edema. Systemic symptoms including fever and tachycardia may be present although thought to be less frequent in older persons \[[@bib2], [@bib3], [@bib4], [@bib5], [@bib6]\]. Known risk factors for cellulitis are venous edema, lymphedema, skin conditions, traumatic injury, leg ulcers, peripheral vascular disease, fungal infections, past history of cellulitis and obesity \[[@bib7], [@bib8], [@bib9], [@bib10]\].

Age alone does not alter treatment principles for bacterial cellulitis (including use of antibiotics); however age-related pharmacokinetics and pharmacodynamics, cognitive status and social circumstances \[[@bib11]\] may impact on treatment decisions particularly need for hospitalization.

Once hospitalized, age is an independent risk factor for increased length of stay for cellulitis with other factors being long duration of symptoms, tachycardia, hypotension, leukocytosis, hypoalbuminemia, elevated serum creatinine, bacteremia, obesity and diabetes mellitus \[[@bib12], [@bib13], [@bib14], [@bib15]\].

Age is significantly associated with increased mortality from cellulitis although it is unclear if this is due to illness severity or underlying comorbidity \[[@bib16]\]. Other factors associated with mortality are delayed administration of antibiotics, presence of multiple comorbidities, previous myocardial infarction, congestive heart failure, liver disease, hypoalbuminemia, renal insufficiency, morbid obesity, lower limb edema, *Pseudomonas aeruginosa* infection, bacteremia and septic shock \[[@bib14],[@bib17]\].

Hospital readmission for cellulitis is also more common in older people \[[@bib18]\] particularly if there has been more than one prior episode of cellulitis^19.^

2. Aims {#sec2}
=======

In this prospective study, we aimed to examine differences in risk factors, clinical features, management, and outcomes of cellulitis between those 75 years or more and those less than 75 years admitted to a large metropolitan hospital.

3. Methods {#sec3}
==========

The study was conducted at Bankstown-Lidcombe Hospital, New South Wales, Australia from June 2014 to April 2015. The study was approved by the South-Western Sydney Local Health District (SWSLHD) Ethics Committee.

Between June 2014 and April 2015, potential patients were identified through review of the Bankstown Hospital inpatient list three times a week by a study investigator. We included all identified patients aged 18 years or more with a diagnosis of cellulitis of the upper and/or lower limb(s) and excluded patients with infected ulcers on presentation, pregnant patients and those with post-operative wound infections.

The patients were then stratified into an older group (aged 75 years or more) and a younger group (74 years or less) and were followed up during their admission and for a total of 28 days post completion of intravenous antibiotics. We studied the over 75 years age group as that this age group is more descriptive of the frail older cohort \[[@bib19]\].

Data collected included basic demographics, clinical characteristics, relevant investigations, treatment provided and clinical outcomes. The severity of cellulitis was rated using the Eron classification \[[@bib20]\].

Data were analyzed with SPSS Version 24 and R version 3.3.1. Chi-square test was used to compare proportions. Student\'s T-test was used to compare differences in means for normally distributed variables. For non-normally distributed continuous variables, non-parametric test was used to assess differences in the ranked median scores. Logistic regression was used to assess statistically significant risk factors for cellulitis in the older and younger age groups. Statistically significant results were set at an alpha level of 0.05. The study is in line with the STROCSS guidelines \[[@bib21]\]. The study also been registered on the research registry UIN:researchregistry5125.

4. Results {#sec4}
==========

One hundred and thirteen patients were identified during the study period and 100 patients (88.5%) consented to participate. Thirty-one (31.0%) patients were aged 75 years and older and 69 (69.0%) patients were 74 years or less.

The mean age was 84.4 ± 5.8 years in the older group and 53.4 ± 14.2 years in the younger group. The older patients had lower BMI than their younger counterparts \[28.3 (±8.0) vs 36.0 (±12.3) respectively, p \< 0.001\]. A higher proportion resided in residential aged care facilities (25.8% vs 2.9% respectively, p = 0.001); and mobilized with walking aid(s) (58.1% vs 11.6% respectively, p \< 0.001). ([Table 1](#tbl1){ref-type="table"}).Table 1Patient characteristics.Table 1Age \<75 years (N = 69)Age 75 + years (N = 31)P-valueAge mean(SD)53.4 (±14.2)84.4 (±5.8)\<0.001Female n (%)23 (33.3%)16 (48.5%)0.12BMI36.0 (±12.3)28.3 (±8.0)\<0.001Residential Aged Care Facility2 (2.9%)8 (25.8%)0.001Mobility\<0.001 Mobile unaided61 (88.4%)13 41.9%) Mobile with aid8 (11.6%)18 (58.1%)**Risk factors**[a](#tbl1fna){ref-type="table-fn"} OR (95% CI) Dependent edema--4.0 (1.3--12.6)0.018 Obesity (BMI\>30)--0.3 (0.1--0.8)0.012 Previous cellulitis--0.3 (0.1--1.0)0.044 Peripheral vascular disease--3.1 (0.9--10.6)0.079 Tinea pedis--0.9 (0.2--4.1)0.930 Venous dermatitis--0.5 (0.1--2.0)0.302**Comorbidities** Hypertension16 (23.2%)14 (45.2%)0.035 AF4 (5.8%)11 (33.5%)\<0.001 Dementia1 (1.4%)7 (22.6%)0.001 Malignancy1 (1.4%)5 (16.1%)0.010 Diabetes23 (31.9%)6 (19.4%)0.24 IHD11 (15.9%)10 (32.3%)0.11 CCF10 (14.5%)9 (29.0%)0.10 DVT3 (4.3%)5 (16.1%)0.10 PE2 (2.9%)5 (16.1%)0.072 Steroid use last 3 months3 (4.3%)3 (9.7%)0.37[^1]

A significantly higher proportion of older patients had documented hypertension (45.2% vs 23.2% respectively p = 0.035), atrial fibrillation (33.5% vs 5.8% respectively, p \< 0.001), dementia (22.6% vs 1.4% respectively, p = 0.001) and malignancy (16.1% vs 1.4% respectively, p = 0.010). ([Table 1](#tbl1){ref-type="table"}).

In terms of cellulitis risk factors, after controlling for potential confounders, older patients were more likely to have dependent edema (OR 4.0 95%CI 1.3--12.6, p = 0.018); but less likely to be obese (OR 0.3, 95%CI 0.1--1.0, p = 0.012) or had a prior history of cellulitis (OR 0.3, 95%CI 0.1--1.0, p = 0.044) than younger patients. The risk of peripheral vascular disease, tinea pedis and cutaneous dermatitis were similar in both groups.

Cellulitis presenting features such as pain, fever, chills and vital signs (temperature, heart rate and blood pressure) did not significantly differ between the two groups. The severity of cellulitis, as defined by the Eron classification \[[@bib22]\] also did not differ between groups with the majority of patients having Eron Classes I and II ([Table 2](#tbl2){ref-type="table"}**).**Table 2Clinical characteristics.Table 2Age \<75 years (N = 69)Age 75 + years (N = 31)P-valueDuration of symptoms median (IQR)3.0 (2.0--6.0)4.0 (2.0--14.0)0.23Fever and chills19 (27.5%)6 (19.4%)0.46Heart rate92 (±17)89 (±15)0.384BP -- Systolic136 (±18)143 (±24)0.158BP \_Diastolic75 (±12)72 (±11)0.227Temperature37.4 (±1.0)37.3 (±1.0)0.796**Pain score**0.055 Mild 0-332 (51.6%)14 (53.8%) Moderate 4-720 (32.3%)12 (46.2%) Severe 8-1010 (16.1%)0**Pathology** Haemoglobin135.0 (±19.4)122.1 (±16.4)0.002 White cell count11.3 (±5.1)11.1 (±6.0)0.61 Albumin41.4 (±4.1)38.0 (±4.7)0.001 Creatinine -- median (IQR)88 (76--106)93 (71--131)0.692 Urea -- median (IQR)5.8 (4.8--8.4)7.9 (5.8--12.4)0.011 CRP -- median (IQR)33 (15--117)60 (9--133)0.919 Blood culture29 (42.0%)18 (58.1%)0.071**Eron Classification**0.415Class I10 (14.5%)2 (6.5%)Class II55 (79.7%)26 (83.9%)Class III4 (5.8%)3 (9.7%)Class IV00[^2]

Initial laboratory results revealed that older patients had lower hemoglobin \[122.1 (±16.4) vs 135.0 (±19.4), p = 0.002\] and albumin \[38.0 (±47) vs 41.4 (±4.1), p \< 0.001\] and higher urea level \[7.9 (5.8--12.4) vs 5.8 (4.8--8.4), p = 0.011\] compared to their younger counterparts. CRP white cell count (WCC) and positive rate of blood culture did not differ between the two groups ([Table 2](#tbl2){ref-type="table"}**).**

Older inpatients presenting with cellulitis were less likely to be referred to hospital in the home (HITH) antibiotic programs for completion of the course of intravenous antibiotics 32.3% vs 59.4% respectively, p = 0.012) compared to younger patients. The antibiotic choices did not differ between the two populations, these included Cephazolin, Flucloxacillin or Tazobactam-Piperacillin.

Older patients with cellulitis were more likely to experience falls or decreased mobility (38.7% vs 15.9% respectively, p = 0.020) compared to the younger group. ([Table 3](#tbl3){ref-type="table"}). Despite this, they had similar LOS to their younger counterparts \[10 (7--15) vs 8 (6--13) respectively, p = 0.403\]. There was one death in each group and the rates of ICU admission, surgical intervention and 28-day readmission were similar in the two groups.Table 3Treatment, complications and outcomes.Table 3CharacteristicsAge \<75 years (N = 69)Age 75 + years (N = 31)P-valueCompleted treatment via HiTH41 (59.4%)10 (32.3%)0.012Duration of IV antibiotic -- median (IQR)6 (4--8)4 (2--9)0.059Length of hospital stay -- median (IQR)8 (6--13)10 (7--15)0.403Antibiotics0.121 Cephazolin47 (51.1%)16 (32.7%) Flucloxacillin20 (21.7%)12 (24.5%) Tazobactam-piperacillin7 (7.6%)4 (8.2%)Complications DVT001 PE01 (3%)0.31 Fall or decreased mobility11 (15.9%)12 (38.7%)0.020 Nosocomial infection1 (1.4%)3 (9.7%)0.087 Delirium1 (1.4%)2 (6.5%)0.23Outcomes Death1 (1.4%)1 (3.0%)0.531 Needing surgical intervention3 (4.3%)2 (6.5%)0.644 ICU admission001 Readmission within 28 days4 (5.8%)00.308Duration of IV antibiotic -- median (IQR)6 (4--8)4 (2--9)0.059Length of hospital stay -- median (IQR)8 (6--13)10 (7--15)0.403Antibiotics0.121 Cephazolin47 (51.1%)16 (32.7%) Flucloxacillin20 (21.7%)12 (24.5%)[^3]

5. Discussion {#sec5}
=============

In this study, we found that older people, despite being frailer than their younger counterparts, had similar treatment outcomes after presenting to hospital with mild to moderate limb cellulitis.

In our study, most of the potential risk factors for cellulitis were similar in the older and younger age groups; however, older patients were more likely to have dependent edema and impaired mobility, and less likely to be obese. Other conditions noted to be more common in the older group were congestive cardiac failure, atrial fibrillation, dementia and malignancy. We believe this finding reflected the higher prevalence of these conditions in the older population rather than an association with cellulitis.

Over 25% of older patients with cellulitis lived in residential aged care facilities. This finding raised the opportunity for the provision of ambulatory care antibiotic programs in aged care homes potentially avoiding the need for hospitalization for residents with cellulitis.

There were no significant differences in the clinical presentation of cellulitis between the two age groups (i.e., duration of cellulitis symptoms, heart rate, blood pressure, temperature, white cell count, CRP and Eron severity classification). Atypical and blunted physiological response to infection with age has been documented in the literature \[[@bib23]\]. In severe sepsis, a reduced physiological response can lead to rapid progression of sepsis \[[@bib2],[@bib3],[@bib22]\].Our results did not support a blunted response to infection in older patients with cellulitis. We, however, did not have any patients with severe sepsis to examine the inflammatory response in more detail.

In our study, older patients experienced more falls and impaired mobility during the admission for cellulitis compared to younger patients. While these factors might have made their hospital discharge planning more complex, they did not translate into an increased hospital length of stay. Previously described risk factors affecting LOS in cellulitis *(comprising of age, hypoalbuminemia, bacteremia, obesity, diabetes mellitus, tachycardia, hypotension, leukocytosis, and elevated serum creatinine)* \[[@bib7],[@bib12], [@bib13], [@bib14], [@bib15]\], tended to be skewed towards age and hypoalbuminemia for the older group and obesity for the younger group in our study.

There were no statistically significant differences between the two groups in terms of mortality, ICU admission, and surgical intervention for cellulitis complications. The majority of patients in both groups had Eron Class I or II cellulitis and did not sustain physiological decompensations; however, in more severe cases of cellulitis, one would expect ageing physiology to sustain more physiological decompensations which may then influence the above parameters.

A lower proportion of older inpatients discharged to HITH programs might have been attributable to their medical comorbidities and functional criteria not meeting HITH requirements. As such, additional health resources may allow HITH programs to manage these complex patients but this would require further study.

Unlike previous published literature \[[@bib18]\], we did not find a significant difference in the 28-day readmission rate between the two age cohorts in our study. As the readmission rate was less than 5%, a study with greater number of patients would have more power to detect small differences in readmission rates.

One of the limitations of this study is the small sample size due to a short recruitment period; further study with a larger sample size would assist in validation of our findings. We decided to focus on inpatient cellulitis treatment; however a cellulitis management journey from hospital to community settings would have provided with a more complete picture.

As the number of older patients presenting with cellulitis increases as the population ages, it is important to note that for mild to moderate cellulitis, older patients perform just as well as younger patients with standard cellulitis treatments on clinical and care indicators.
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[^1]: Logistic regression -- Chi-square = 17.868, p = 0.007, df = 6, Nagelkerke\'s R2 0.230; BMI body mass index; IHD ischaemic heart disease; AF atrial fribrillation; CCF congestive cardiac failure; DVT deep vein thrombosis; PE pulmonary embolism.

[^2]: BP blood pressure; CRP C reactive protein.

[^3]: HiTH hospital in the home; DVT deep vein thrombosis; PE pulmonary embolism.
